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Abstract
Maintenance of airway secretion clearance, or airway hygiene, is
important for the preservation of airway patency and the prevention
of respiratory tract infection. Impaired airway clearance often
prompts admission to the intensive care unit (ICU) and can be a
cause and/or contributor to acute respiratory failure. Physical
methods to augment airway clearance are often used in the ICU
but few are substantiated by clinical data. This review focuses on
the impact of oral hygiene, tracheal suctioning, bronchoscopy,
mucus-controlling agents, and kinetic therapy on the incidence of
hospital-acquired respiratory infections, length of stay in the
hospital and the ICU, and mortality in critically ill patients. Available
data are distilled into recommendations for the maintenance of
airway hygiene in ICU patients.
Introduction
Clearance of airway secretions, or airway hygiene, is a normal
physiological process needed for the preservation of airway
patency and the prevention of respiratory tract infection.
Impaired clearance of airway secretions can result in
atelectasis and pneumonia, and may contribute to respiratory
failure prompting admission to an intensive care unit (ICU).
Physical methods to augment the clearance of secretions are
often used in the ICU. This review focuses on mechanical
methods and pharmacological agents commonly used to
maintain airway hygiene in the ICU, and their effect on clinical
outcomes of critically ill patients. The impact of oral hygiene,
tracheal suctioning, bronchoscopy, mucus-controlling agents,
and kinetic therapy on the incidence of nosocomial
respiratory infections, length of stay in the hospital and the
ICU, and mortality will be discussed. Where possible, we
have distilled available data into recommendations for airway
hygiene in ICU patients.
Methods
Literature for this article was identified by searching the
PubMed database (1966 to present). English-language
articles of relevance were selected and reviewed. Additional
resources were obtained through the bibliographies of
reviewed articles. The following search terms were used:
airway hygiene, oral hygiene, mucociliary clearance, tracheal
suctioning, bronchoscopy, mucolytics, chest physiotherapy,
kinetic therapy, continuous lateral rotational therapy, selective
digestive decontamination, nosocomial pneumonia, hospital-
acquired pneumonia, ventilator-associated pneumonia, and
pneumonia.
A summary of recommendations and associated strength of
supporting evidence for strategies used in the reduction of
nosocomial pneumonia is shown in Table 1. The following
grading system described by Kollef [1] was used to assess
strength of evidence: A, supported by at least two ran-
domized, controlled investigations; B, supported by at least
one randomized, controlled investigation; C, supported by
nonrandomized, concurrent-cohort investigations, historical-
cohort investigations, or case series; U, undetermined or not
yet studied in clinical investigations.
Oral/pharyngeal hygiene
A general tenet of hospital-acquired pneumonia and ventilator-
associated pneumonia (VAP) is that infections of the lower
respiratory tract are preceded by colonization or infection of
the upper airway. Thus, most hospital-acquired pneumonias
stem from micro- or macro-aspiration of infected secretions
from the upper airway. Methods that reduce oropharyngeal
colonization have been postulated to reduce infections of the
lower respiratory tract in the critically ill. Surprisingly,
nasopharyngeal and oropharyngeal hygiene often receives
little attention from intensivists.
Many risk factors have been linked to airway colonization,
including severity of illness, length of hospitalization, prior or
concomitant antibiotic use, malnutrition, endotracheal intu-
bation, azotemia, underlying pulmonary disease, inadequate
Review
Clinical review: Airway hygiene in the intensive care unit
Sanja Jelic, Jennifer A Cunningham and Phillip Factor
Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, 
New York, NY 10032, USA
Corresponding author: Sanja Jelic, sj366@columbia.edu
Published: 31 March 2008 Critical Care 2008, 12:209 (doi:10.1186/cc6830)
This article is online at http://ccforum.com/content/12/2/209
© 2008 BioMed Central Ltd
CLRT = continuous lateral rotation therapy; CPAP = continuous positive airway pressure; ICU = intensive care unit; IS = incentive spirometry; NAC =
N-acetylcysteine; SDD = selective digestive decontamination; VAP = ventilator-associated pneumonia.Page 2 of 9
(page number not for citation purposes)
Critical Care    Vol 12 No 2 Jelic et al.
oral hygiene, substandard infection control practises during
bathing, tracheal suctioning, enteral feeding, and endo-
tracheal tube manipulation. Furthermore, critical illness is
associated with alterations in oral mucosal-cell-surface fibro-
nectin and carbohydrate expression patterns, disruption of
the mucosa by endotracheal tubes and suction catheters,
and increased secretion of mucus, all of which provide
binding sites for pathogenic bacteria [2-5]. Gram-negative
bacteria and Staphylococcus aureus replace the normal
upper-airway flora of patients hospitalized for more than
5 days [6]. Not surprisingly, many patients (50%) have
pathogenic bacteria in their oropharynx on admission to the
ICU [7]. The periodontal areas, oropharynx, sinuses, stomach,
and trachea are colonized by the end of the first week in most
mechanically ventilated patients [7-9]. Tracheal and oro-
pharyngeal colonization is associated with VAP, whereas
gastric colonization in the setting of acid suppression therapy
may not be [7,8,10].
Oral antiseptic rinses such as chlorhexidine gluconate reduce
the rate of nosocomial pneumonia in critically ill patients [11-
13]. The twice-daily use of chlorhexidine gluconate 0.12%
oral rinse reduced respiratory tract infections by 69% and
antibiotic use by 43% in cardiac surgical patients post-
operatively without affecting antibiotic resistance patterns
[11]. The impact was greatest in patients intubated for more
than 24 hours and who had the highest degree of bacterial
colonization [13]. The cost of nursing care did not signifi-
cantly increase with the use of chlorhexidine oral rinse, and
the liquid form was easier and quicker to apply than an
antibiotic paste [11,13]. Despite the reduction in bacterial
colonization and/or nosocomial pneumonia, the use of oral
antiseptic rinses has not been shown to affect the duration of
mechanical ventilation or survival, although it may modestly
reduce the length of stay in the hospital [12,14].
Selective decontamination of the oropharynx, and gastric and
subglottic area, or selective digestive tract decontamination
(SDD) with several different regimens have been proposed as
a method for decreasing VAP. These SDD regimens have
included one or more of the following antibiotics: polymixin,
tobramycin/gentamycin, vancomycin, and amphotericin B
suspension. More than 50 randomized controlled trials and
12 meta-analyses evaluating the SDD prophylaxis have been
Table 1
Recommendations for airway hygiene in critically ill patients for reduction in health-care-associated pneumonia
Recommended for  Reduction in  Reduction in 
Strategies clinical use Grade HCAP mortality Refs
Effective strategies
Chlorhexidine gluconate oral rinse Yes A Yes No 11–14
Endotracheal suctioning on ‘as needed’ basis  Yes A No increased incidence of HCAP No 45,57,58
(compared with routine suctioning)
Kinetic therapy Yesa A Inconclusive No 105–111
Ineffective strategies
Selective digestive decontamination No A Inconclusive No 15–33
Oral topical iseganan No B No No 35
Aerosolized mucus-controlling agents No U N/A N/A 85–88
Endotracheal instillation of saline No C N/A N/A 52,53
Chest physiotherapy No A Inconclusive No 114,
117–125
Strategies of equivocal or undetermined effectiveness
Continuous subglottic suctioning Yesb A Yes No 70–75
Bronchoscopy Yesc B N/A N/A 114
Closed (in-line) endotracheal suctioning  Yesd A Inconclusive No 59–68
(compared with open suctioning)
The grading scheme used is as follows: A, supported by at least two randomized, controlled investigations; B, supported by at least one
randomized, controlled investigation; C, supported by nonrandomized, concurrent-cohort investigations, historical-cohort investigations, or case
series; U, undetermined or not yet studied in clinical investigations. HCAP, healthcare-associated pneumonia; N/A, not applicable. aThe increased
cost of kinetic beds is offset by the decreased length of stay; bthis strategy is recommended for patients expected to require more than 72 hours of
mechanical ventilation; cthis strategy is recommended for patients with acute atelectasis involving more than a single lung segment in the absence
of air bronchograms who remain symptomatic after 24 hours of chest physiotherapy; dthis strategy is recommended for patients requiring
mechanical ventilation for more than four days.Page 3 of 9
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published [15-29]. These trials were conducted in unselected
medical and surgical patients who required 2 days or more of
mechanical ventilation and in selected patients including liver
transplant, cardiac surgical, and burn patients. Most
randomized control trials found a beneficial effect in reduction
of bacterial colonization and/or VAP; however, effects on
length of stay in the ICU and mortality are inconsistent.
Although some analyses suggest a reduction in mortality in
selected patients [24,27], others have demonstrated only a
modest effect with the use of combined (topical and
systemic) SDD therapy [18,19,23]. Survival advantage
seems to be limited to surgical ICU patients treated with a
combination of parenteral and topical prophylactic antibiotics
[18,24,30]. A modified SDD regimen that includes oral
vancomycin reduces the rate at which isolates of methicillin-
resistant  Staphylococcus aureus are found [31,32]. The
impact of this regimen on the incidence of nosocomial
pneumonia is less clear [31,32]. Furthermore, a transient
increase in isolation of vancomycin-resistant Enterococcus
has been observed with this regimen [32]. Failure of SDD
strategies to reduce morbidity and mortality consistently in
critically ill patients may be related to suboptimal study design,
the emergence of antibiotic-resistant bacteria, and an
alteration in hosts’ normal bacteriologic flora [33]. Additional
toxicity and increased healthcare costs related to SDD
[17,27,34] have further dampened the enthusiasm for this
preventive strategy. On the basis of available evidence, SDD
with topical antibiotics should not be routinely used in the ICU.
If combined parenteral and topical SDD is used in surgical/
trauma patients, clinicians should be vigilant in monitoring for
the emergence of new multidrug-resistant organisms.
A recent randomized controlled trial of oral topical iseganan,
an antimicrobial peptide with a broad in vitro activity against
aerobic and anaerobic Gram-positive and Gram-negative
bacteria and yeasts, was stopped early because of a higher,
although not statistically significant, rate of VAP and death
among mechanically ventilated ICU patients in the iseganan
arm [35]. The widespread use of biocides such as
chlorhexidine in hospital, domiciliary, industrial, and other
settings raises concern for the development of antibiotic-
resistant infection. Fortunately, no clinically significant
alteration of antibiotic resistance patterns has been noted in
epidemiologic studies [36,37]. Therefore, chlorhexidine
gluconate oral rinse, an inexpensive and easily applied agent,
should be a routine aspect of care of the critically ill patient.
Tracheal suctioning
Airway hygiene is impaired in critically ill patients as a result
of depressed cough reflex and ineffective mucociliary clear-
ance from sedation, high inspired oxygen concentrations,
elevated endotracheal tube cuff pressure, and tracheal
mucosal inflammation and damage [38-40]. Accordingly, care
of intubated patients includes tracheal suctioning to facilitate
the removal of airway secretions. Routine suctioning via
endotracheal tubes is often performed on the basis of the
assumption that it maintains airway patency and prevents
pulmonary infection. However, tracheal suctioning induces
mucosal injury, exposing the basement membrane and
thereby facilitating bacterial adhesion in vitro [41] and in low-
birthweight babies [42]. Suctioning has also been associated
with many deleterious effects including decreased arterial
oxygen tension (12 to 20 mmHg) [43-45], which may be
more pronounced in cardiac surgical patients [43] and in
patients with hypoxemic respiratory failure requiring high
levels of positive end-expiratory pressure [46], in patients
with cardiac arrhythmias (7 to 81%) [45,47], and in cardiac
arrest in patients with acute spinal cord injury [48]. These
detrimental effects of tracheal suctioning, however, may be
mimimized through the use of manual hyperinflation,
preoxygenation, sedation, and optimal suctioning technique
[49-51]. Normal saline is frequently instilled into the trachea
before endotracheal suctioning under the assumption that it
may help dislodge secretions and facilitate airway clearance.
However, Ackerman and colleagues have shown that
intratracheal instillation of 5 ml of normal saline adversely
effects oxygen hemoglobin saturation and has no effect on the
clearance of secretions [52,53]. In addition, a 5 ml saline
instillation dislodges fivefold more viable bacterial colonies from
the endotracheal tube than does the insertion of a tracheal
suction catheter alone [54] and is associated with prolonged
deoxygenation [55,56]. Limiting the frequency and duration of
tracheal suctioning and limiting the use of saline instillation may
prevent its adverse effects without affecting the duration of
mechanical ventilation, length of stay in the ICU, mortality in the
ICU, and incidence of pulmonary infection [45,57,58]. Thus,
tracheal suctioning of intubated patients should be performed
on an as-needed basis that is defined by the quantity of
secretions obtained, not at prescribed, set intervals.
Closed (in-line), repeated-use endotracheal suction devices
have become commonplace in ICUs. These devices eliminate
the need for disconnection from mechanical ventilation and
do not require single-hand sterile technique of open suction
methods. Available data on the effect of these catheters on
tracheal colonization are conflicting [59,60]. A single study
has reported that in-line suction systems are associated with
a reduction in the incidence of VAP [61], but most studies
and a recent meta-analysis find no beneficial effect on
nosocomial pneumonia [59,62-64]. Their cost-effectiveness,
however, is questionable, with some studies demonstrating
cost savings [65,66] and others suggesting higher costs
associated with closed systems [62,63,67,68]. Despite the
failure of closed endotracheal suctioning systems to reduce
VAP or mortality, these devices may be preferable because of
their efficiency and smaller number of suction-induced
complications [65] and cost-effectiveness among patients
requiring more than 4 days of mechanical ventilation [66].
Routine changes of these devices are not required [69].
A more recent development is the use of endotracheal tubes
with a dorsal suction channel that opens immediately before
Available online http://ccforum.com/content/12/2/209the inflatable cuff in the subglottic area. Suction can be
applied via this port continuously or intermittently for
purposes of removing secretions from the subglottic space. A
recent meta-analysis reported that these endotracheal tubes
reduce early-onset VAP in patients expected to require more
than 72 hours of mechanical ventilation. Early-onset VAP was
defined as pneumonia occurring 5 to 7 days after intubation.
Duration of mechanical ventilation, the length of ICU stay, and
mortality were not different when intention-to-treat data were
summarized [70]. However, subglottic suctioning does not
alter oropharyngeal or tracheal bacterial loads [71], nor does
it significantly reduce the duration of mechanical ventilation,
length of ICU stay, or mortality [70,72-75]. Furthermore,
continuous aspiration of subglottic secretions can cause
severe tracheal mucosal damage [76]. Endotracheal tubes
with a dorsal suction channel are significantly more expensive
than standard endotracheal tubes, increase nursing workload,
and therefore have the potential to increase ICU costs [77]. A
case cost analysis model suggests a potential cost-saving
associated with the use of subglottic suctioning primarily if
these tubes decrease the length of the ICU stay [77], which
has not been observed [72-75]. The use of endotracheal
tubes that allow subglottic suctioning outside populations
with a high incidence of early-onset VAP cannot be recom-
mended at present.
Mucus-controlling agents
Distilled water, normal saline, hypertonic and hypotonic saline
have long been used to ‘loosen’ thick airway secretions and
promote airway hygiene. However, formed mucus does not
readily incorporate topically applied water [78]. Increased
sputum production and clearance attributed to bland
aerosols, especially hypertonic saline, may be due to the
irritant nature of the aerosol, which may cause broncho-
constriction rather than mucolysis [79-81].
N-Acetylcysteine (NAC) is a mucolytic agent that breaks
disulfide bonds of mucus, reducing its viscosity and elasticity,
and has anti-inflammatory properties in experimental models
[79,82]. As a result of its mucolytic properties, many
practioners advocate its use in the ICU for assistance in the
clearance of airway secretions. Although there are limited
data on the use of NAC in ICU patients, it is important for
clinicians to recognize the potential deleterious effects of this
practice. In vitro, NAC may antagonize aminoglycoside and β-
lactam antibiotics [83,84]. Additionally, NAC at concentra-
tions less than 10% inhibits the growth of Pseudomonas
strains in vitro [84], potentially causing false-negative sputum
cultures. Delivery via aerosol thins airway secretions but does
not change pulmonary function or sputum volume in patients
with stable chronic bronchitis [85,86]. Furthermore,
aerosolized NAC can cause bronchoconstriction and inhibit
ciliary function [87,88]. Concomitant administration of a
bronchodilator partly ameliorates NAC-induced broncho-
spasm [89]. Gas exchange may worsen acutely after NAC
administration, possibly because liquefied secretions
gravitate into smaller airways [90]. Tracheal instillation of
NAC through an endotracheal tube or bronchoscope may
induce the rapid accumulation of liquefied secretions that
must be suctioned immediately to prevent asphyxia [91].
Direct  tracheal instillation of NAC is more effective than
aerosol inhalation in the treatment of atelectasis caused by
mucoid impaction [92,93]; however, it remains unclear
whether undirected instillation of NAC results in delivery to
areas of mucus accumulation. Thus, despite its widespread
use, few data are available to support NAC as a mucolytic
agent. Dornase alfa (recombinant human DNase) is used as
a mucolytic in cystic fibrosis and other bronchiectatic con-
ditions [94,95]. Case reports of its use in status
asthmaticus [96], acute respiratory distress syndrome [97],
and mechanically ventilated pediatric patients [94,98] have
been published but no prospective efficacy studies are
available to support its use in adult ICU patients for airway
hygiene.
β2-Adrenergic agonists increase ciliary beat frequency in
experimental models, raising the possibility that they may be
useful for airway hygiene [99]. Salbutamol increases large-
airway mucociliary clearance, both in stable patients with
chronic obstructive pulmonary disease and in healthy
subjects [100], although this may not be true for smaller
airways [101]. There are no data from ICU patients. Thus,
despite the simplicity and attractiveness of this approach,
there are no data to support the use of inhaled β2-adrenergic
agonists as adjuncts for airway hygiene in ICU patients.
Kinetic therapy
Immobility impairs cough and mucociliary clearance in
patients receiving mechanical ventilation, thereby promoting
retention of secretions [102,103]. Kinetic therapy with beds
that intermittently or continuously rotate patients along their
longitudinal axis by 40° or more have gained acceptance in
the care of the critically ill patients [104].
A modest body of data regarding the effect of kinetic beds for
continuous lateral rotation therapy (CLRT) to facilitate airway
hygiene is available. Some of these studies found that CLRT
reduced the incidence of pneumonia and decreased the
length of stay in the ICU in heterogeneous groups of critically
ill patients receiving mechanical ventilation [105-109].
Conversely, other studies detected no meaningful effect on
measures of care in the ICU [110,111]. Differences in
diagnostic criteria for nosocomial pneumonia and variable
use of broad-spectrum antibiotics in treatment and control
groups may be responsible for the diametrically opposed
results of these studies. Importantly, three of the five studies
demonstrating benefit from CLRT were supported by kinetic
bed manufacturers [105-107]. Data from these studies
support the use of CLRT in critically ill patients. The
increased cost of CLRT is offset by reduced nosocomial
pneumonia and antibiotic use and a decreased length of stay
in the hospital and the ICU [106,108,109,112].
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Chest physiotherapy, including gravity-assisted drainage,
chest wall percussion, chest wall vibrations, and manual lung
hyperinflation, aids in the re-expansion of atelectatic lung
[113-115] and increases peak expiratory flow rates [116].
Chest physiotherapy treatment is as effective as early
bronchoscopy in patients with acute atelectasis [114]. A
single study examined the role of chest physiotherapy in
patients at high risk for post-operative respiratory failure. Hall
and colleagues randomized 301 spontaneously breathing
patients at high risk for respiratory complications to receive
incentive spirometry (IS) or IS plus chest physiotherapy after
abdominal surgery [117]. The incidence of respiratory
complications was not significantly different between two
study groups. The inclusion of physiotherapy, however,
required 30 minutes of staff time per patient. A recent meta-
analysis examined the role of various chest physiotherapy
techniques including IS, deep breathing exercise, chest
physical therapy (cough, postural drainage, percussion/
vibration, suction, and ambulation), intermittent positive-
pressure breathing, and continuous positive airway pressure
(CPAP) [118]. In patients who underwent abdominal
surgery, any type of lung expansion technique was better
than no intervention in the prevention of pulmonary
complications. Although no particular intervention seemed
superior, IS may require the least staff time, while CPAP may
be particularly beneficial in patients who have limited ability
to participate with other physiotherapy techniques [118]. In
contrast, others reported poor adherence to an independent
use of IS among patients recovering from surgery and
superiority of encouragement by hospital personnel to the
use of IS [119,120]. Current evidence does not support the
use of IS in the prevention of complications after cardiac or
abdominal surgery [121,122]. When nosocomial pneumonia
is used as a specific endpoint, only one study showed the
beneficial effect of physiotherapy [123]. Routine chest
physiotherapy therefore cannot be recommended for
prophylaxis against respiratory complications in spon-
taneously breathing patients.
There are mixed data about chest physiotherapy in
mechanically ventilated patients. A single study of patients
receiving mechanical ventilation for 48 hours or more
showed a reduced incidence of VAP [124], whereas a
second trial in trauma patients was unable to detect an
effect on nosocomial pneumonia rates [125]. Furthermore,
chest physiotherapy may cause cardiac arrhythmias,
bronchospasm, and transient hypoxemia, and may prolong
the duration of mechanical ventilation [126-128]. These
complications, as well as increased staff use and cost,
combined with a paucity of data regarding beneficial effects
on the prevention of nosocomial pneumonia, should limit the
use of chest physiotherapy to the ICU patients with acute
atelectasis, exacerbations of bronchiectasis, and conditions
that are characterized by excessive sputum production and
impaired cough.
Limited data are available about flutter valves, cornet type
devices, or intrapulmonary percussive ventilation in ICU
patients. Cough assist devices, which generate a strong
expiratory flow through the application of positive pressure
followed by the application of negative pressure, have been
shown to aid in the removal of secretions [129,130] and may
avoid intubation in patients with neuromuscular disease
[131]. However, the long-term benefit of these devices in
other ICU populations is unclear. A small study of pneumatic
high-frequency chest compression in long-term mechanically
ventilated patients found it to be just as efficacious as
percussion and postural drainage [132], and another study of
patients immediately after cardiopulmonary bypass surgery
reported reduced sternotomy pain with cough [133].
Bronchoscopy for atelectasis
Atelectasis occurs when alveolar closing volume rises above
functional residual capacity and is rarely due to proximal
airway obstruction by mucus. Critically ill patients have
elevated closing volumes as a result of increased lung water,
advanced age, and low functional residual capacity due to
respiratory muscle weakness, sedation, and supine
positioning [134]. Fiberoptic bronchoscopy is frequently
requested and often performed for ‘pulmonary toilet’ or
treatment of atelectasis in critically ill patients; however, its
utility in improving gas exchange and preventing nosocomial
pneumonia is limited. Only one randomized study compared
the efficacy of fiberoptic bronchoscopy with chest physio-
therapy for the treatment of acute atelectasis [114]. Thirty-
one consecutive patients with acute lobar atelectasis were
randomly assigned to receive immediate fiberoptic broncho-
scopy with airway lavage followed by chest physiotherapy
every 4 hours for 48 hours or to receive chest physiotherapy
alone. Patients who were assigned to chest physiotherapy
alone underwent ‘delayed fiberoptic bronchoscopy’ if their
atelectasis persisted at 24 hours. Radiographic resolution of
lung volume loss with bronchoscopy was similar to that after
the first chest physiotherapy treatment in the control group
(38% versus 37%). Although half of the patients who were
randomized to chest physiotherapy alone underwent ‘delayed’
bronchoscopy, this study provided the impetus for teaching
pulmonologists-in-training that there is rarely a role for
bronchoscopy for atelectasis. In addition, bronchoscopy in
patients with acute or incipient respiratory failure is not
without adverse effects. Deterioration of gas exchange,
barotrauma from elevated airway pressures, increased
myocardial oxygen demand, and intracranial pressure have
been reported [135-138]. Nevertheless, subgroup analysis
[114], case series [137,139-143], and clinical experience
support a role for bronchoscopy for some patients with
atelectasis: specifically, critically ill patients with acute whole-
lung, lobar, or segmental atelectasis without air broncho-
grams [114] who are unable to maintain airway hygiene
independently and remain symptomatic after 24 hours of
aggressive chest physiotherapy (every 4 hours). Clinical
experience indicates that atelectasis recurs frequently after
Available online http://ccforum.com/content/12/2/209
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hygiene continues. Thus, failure to resolve the primary
problem should not be an indication for repeated invasive
intervention in the airways. There is no role for empiric
‘cleaning of the airways’ with a bronchoscope.
Conclusion
The rationale for airway hygiene is the prevention of
pneumonia and respiratory failure. Current practice reflects
clinical experience and expert opinion and not the results of
controlled clinical trials. Several evidence-based recommen-
dations can now be made about airway hygiene in critically ill
patients. First, oropharyngeal decontamination with oral
biocide rinses reduces the incidence of nosocomial pneu-
monia and should be part of the routine care of the
mechanically ventilated patient. Careful monitoring of anti-
biotic resistance patterns after the initiation of routine biocide
use is prudent at this time. Second, tracheal suctioning
should be performed only on an ‘as needed’ basis. Closed
(in-line) suction catheter devices should be used and routine
changes of these devices are not necessary. Third,
aerosolized mucus-controlling agents, such as NAC, and
routine instillation of saline have no demonstrable effect on
the clearance of airway secretions and should not be
routinely used in critically ill patients. Fourth, kinetic therapy
decreases the rate of nosocomial pneumonia, and may
reduce the length of stay in the ICU and the hospital. The
high cost of kinetic beds may be offset by a shortening of
stay and a decreased use of systemic antibiotics. Fifth, chest
physiotherapy should be limited to patients with acute
atelectasis and/or excessive sputum production who are
unable to conduct airway hygiene independently. Sixth, the
therapeutic role of bronchoscopy in acute atelectasis is
limited and transient, and should be reserved primarily for
patients with acute atelectasis involving more than a single
lung segment in the absence of air bronchograms who
remain symptomatic after 24 hours of chest physiotherapy.
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